Laboratory Automation in Microbiology: Impact on Turnaround Time of Microbiological Samples in COVID Time
Diagnostics · 01.07.2023 · 13 (13) · 2243
DOI: 10.3390/diagnostics13132243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 01.07.2023. Verfasst von Carla Fontana und 12 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Laboratory Automation (LA) is an innovative technology that is currently available for microbiology laboratories. LA can be a game changer by revolutionizing laboratory workflows through efficiency improvement and is also effective in the organization and standardization of procedures, enabling staff requalification. It can provide an important return on investment (time spent redefining the workflow as well as direct costs of instrumentation) in the medium to long term.
Methods
Here, we present our experience with the WASPLab® system introduced in our lab during the COVID-19 pandemic. We evaluated the impact due to the system by comparing the TAT recorded on our samples before, during, and after LA introduction (from 2019 to 2021). We focused our attention on blood cultures (BCs) and biological fluid samples (BLs).
Results
TAT recorded over time showed a significant decrease: from 97 h to 53.5 h (Δ43.5 h) for BCs and from 73 h to 58 h (Δ20 h) for BLs. Despite the introduction of the WASPLab® system, we have not been able to reduce the number of technical personnel units dedicated to the microbiology lab, but WASPLab® has allowed us to direct some of the staff resources toward other laboratory activities, including those required by the pandemic.
Conclusions
LA can significantly enhance laboratory performance and, due to the significant reduction in reporting time, can have an effective impact on clinical choices and therefore on patient outcomes. Therefore, the initial costs of LA adoption must be considered worthwhile.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
- Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
- Laboratory of Microbiology, Polyclinic of "Tor Vergata", 00133 Rome, Italy.
- Department of Laboratory Medicine, Polyclinic Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.
- Laboratory of Microbiology of Chronic-Neurodegenerative Diseases, IRCCS San Raffaele Roma, 00166 Rome, Italy.
- Department of Human Sciences and Quality of Life Promotion, San Raffaele University, 00166 Rome, Italy.
ORCID-Profile: Carla Fontana
Zitieren
APA
Fontana, C., Favaro, M., Pelliccioni, M., Minelli, S., Bossa, M. C., Altieri, A., D'Orazi, C., Paliotta, F., Cicchetti, O., Minieri, M., Prezioso, C., Limongi, D., & D'agostini, C. (2023). Laboratory Automation in Microbiology: Impact on Turnaround Time of Microbiological Samples in COVID Time. Diagnostics, 13(13), 2243. https://doi.org/10.3390/diagnostics13132243
Vancouver
Fontana C, Favaro M, Pelliccioni M, Minelli S, Bossa MC, Altieri A, et al. Laboratory Automation in Microbiology: Impact on Turnaround Time of Microbiological Samples in COVID Time. Diagnostics. 2023;13(13):2243. doi:10.3390/diagnostics13132243
BibTeX
@article{Fontana2023,
author = {Fontana, Carla and Favaro, Marco and Pelliccioni, Marco and Minelli, Silvia and Bossa, Maria Cristina and Altieri, Anna and D'Orazi, Carlo and Paliotta, Federico and Cicchetti, Oriana and Minieri, Marilena and Prezioso, Carla and Limongi, Dolores and D'agostini, Cartesio},
title = {Laboratory Automation in Microbiology: Impact on Turnaround Time of Microbiological Samples in COVID Time},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {13},
pages = {2243},
doi = {10.3390/diagnostics13132243}
}
EUVIMED